The Role of Cryopreserved Human Amniotic Membrane in the Surgical Repair of Peroneal Tendons: An Infrared Thermography Model (Amniox)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2013 by Orthopedic Foot and Ankle Center, Ohio
Sponsor:
Information provided by (Responsible Party):
Greg Berlet, Orthopedic Foot and Ankle Center, Ohio
ClinicalTrials.gov Identifier:
NCT01708187
First received: September 5, 2012
Last updated: February 12, 2014
Last verified: May 2013
  Purpose

Peroneal tendon tears are a common etiology encountered by foot and ankle surgeons. Like all flexor tendon repairs adhesions are one of the more common challenges after surgery. Peroneal tendon gliding is key to their function as effective plantar flexors and evertors of the hindfoot. Scarring and adhesion correlate directly with the amount of inflammatory reaction at the wound site (Adzick 1994). Our goal is to have a surgical technique that allows for standard suture repair of the tendon yet allows for smooth gliding of the tendon with minimal adhesions. A prospective review on the surgical repair of the peroneal tendons utilizing NEOX™1k (Amniox Medical, Marietta, GA), cryopreserved Human Amniotic Membrane (C-HAM) graft will be performed. The investigators hypothesize that the use of cryopreserved Human Amniotic Membrane in conjunction with a peroneal tendon repair will decrease that amount of inflammation, overall recovery time of surgically repaired peroneal tendon tears, and adhesions.


Condition Intervention
Tendon Tears
Biological: NEOX™1k graft

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Role of Cryopreserved Human Amniotic Membrane in the Surgical Repair of Peroneal Tendons: An Infrared Thermography Model

Resource links provided by NLM:


Further study details as provided by Orthopedic Foot and Ankle Center, Ohio:

Primary Outcome Measures:
  • Decrease in ankle pain, inflammation, function & activity limitation [ Time Frame: one year ] [ Designated as safety issue: No ]

Estimated Enrollment: 40
Study Start Date: October 2012
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: NEOX™1k tissue
Group 1 will have standard peroneal repair surgery with the addition of the NEOX™1k tissue.
Biological: NEOX™1k graft

Group 1 will have standard peroneal repair surgery with the addition of the NEOX™1k tissue.

Group 2 will have standard peroneal repair surgery without the use of the NEOX™1k tissue.

Other Name: cryopreserved Human Amniotic Membrane (C-HAM) graft
No Intervention: Control arm without NEOX™1k tissue
Group 2 will have standard peroneal repair surgery without the use of the NEOX™1k tissue.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Patients requiring surgical repair of the peroneal tendon
  2. Patients who voluntarily consent to research participation
  3. Patients over the age of 18

Exclusion Criteria:

  1. Patients who display a high surgical risk as determined by the investigative surgeon
  2. Previous surgical repair of the peroneal tendon
  3. Patients with allergy or history of drug reactions to Ciprofloxacin or Amphotericin B
  4. Patients who are pregnant or breast feeding.
  5. Patients who have had a clinically diagnosed autoimmune disease
  6. Patients who are unwilling to restrict pre and postoperative anti-inflammatories
  7. Patients with an active infection
  8. Patients who have a medical history that would likely make the patient an unreliable research participant
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01708187

Contacts
Contact: Emily Stansbury 614-895-8747 ofacresearch@orthofootankle.com

Locations
United States, Ohio
Orthopedic Foot and Ankle Center Recruiting
Westerville, Ohio, United States, 43082
Contact: Emily Stansbury, BA    614-895-8747 ext 111    ofacresearch@orthofootankle.com   
Contact: Natalie M Henke, BS    614-895-8747 ext 187    ofacresearch@orthofootankle.com   
Sponsors and Collaborators
Orthopedic Foot and Ankle Center, Ohio
  More Information

No publications provided

Responsible Party: Greg Berlet, MD, Orthopedic Foot and Ankle Center, Ohio
ClinicalTrials.gov Identifier: NCT01708187     History of Changes
Other Study ID Numbers: OH1-12-00396
Study First Received: September 5, 2012
Last Updated: February 12, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Orthopedic Foot and Ankle Center, Ohio:
Peroneal tendon

ClinicalTrials.gov processed this record on August 20, 2014